The Market Journey of Biotech
Translating scientific breakthroughs from the lab to real-world applications requires a seamless integration of scientific, regulatory, and financial expertise, which can be difficult to achieve. High costs, complex regulatory requirements, and the need for specialized skills create barriers that hinder the transition from research to market-ready therapies. Addressing these obstacles will be essential for ensuring that biotechnology fulfills its promise as a strategic pillar for future healthcare resilience and preparedness.
In the new issue of MakingPharmaindustry | The Market Journey of Biotech offers in-depth articles related to the biotechnology market, and offers a focus on Italy, which stands out as an emerging leader in biotechnology, backed by world-renowned scientists and groundbreaking research. However, scientific excellence alone is not enough: the future of advanced therapies will depend on the country’s ability to overcome regulatory, economic, and technology transfer challenges to turn discoveries into effective therapeutic solutions.
The magazine is available for free on MakingConnect, the ecosystem that MakingLife thought of creating a Pharma Community.
To access the magazine, simply click on this link and log in with your credentials, or register if you don’t yet have a MakingConnect account.
Inside the “Exclusive Contents” section you can find the new issue of MakingPharmaindustry and the latest Makinglife Observatories.
Registration is free and also allows you to access all the other dedicated services: agreements, discounts, training, consultancy from the network of professionals who collaborate with MakingLife, exclusive content, business matching tools.
